OxySure Systems, Inc. (OXYS.OB) is a medical device company with a potential breakthrough product for the delivery of medical grade oxygen for the treatment of cardiac and respiratory distress situations. The company has developed a unique platform technology, whereby medically pure oxygen is created instantly from two inert dry powders, allowing oxygen to be delivered on demand to patients when needed.
The Product
The Model 615 unit has been cleared by the U.S. Food and Drug Administration (FDA)...
OxySure (OXYS) Affiliates Convert $2.02 Million in Notes to Common Stock at $1.50 Per Share
Conversion Price represents 52% Premium to Market
Frisco, Texas, January 3, 2013 – OxySure® Systems, Inc. (OTCBB:OXYS) (“OxySure,” or the “Company”),
the medical device innovator of life-saving, easy-to-use emergency oxygen solutions with its “oxygen from
powder” technology today announced that affiliates Agave Resources, LLC and JTR Investments, Limited
converted a total of $2,018,656 in...
Sterling Investments Initiates Coverage on OxySure (OXYS) with a BUY Recommendation
12 Dec, 2012 15:20 CET
Frisco, Texas, December 12, 2012 – OxySure® Systems, Inc. (OTCBB:OXYS) (“OxySure,” or the “Company”), the medical device innovator of life-saving, easy-to-use emergency oxygen solutions with its “oxygen from powder” technology today announced that Sterling Investment Services, Inc. has initiated coverage of OXYS with a BUY recommendation.
A copy of the Sterling research report...